Seroatlas · Human Serome Atlas

PFKFB3

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3

Also known as: F263_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q16875
Gene
PFKFB3
Ensembl
ENSG00000170525
Chromosome
10
Canonical length
520 aa
Protein class
Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm
Quaternary structure
Homodimer

OverviewNCBI Gene

The protein encoded by this gene belongs to a family of bifunctional proteins that are involved in both the synthesis and degradation of fructose-2,6-bisphosphate, a regulatory molecule that controls glycolysis in eukaryotes. The encoded protein has a 6-phosphofructo-2-kinase activity that catalyzes the synthesis of fructose-2,6-bisphosphate (F2,6BP), and a fructose-2,6-biphosphatase activity that catalyzes the degradation of F2,6BP. This protein is required for cell cycle progression and prevention of apoptosis. It functions as a regulator of cyclin-dependent kinase 1, linking glucose metabolism to cell proliferation and survival in tumor cells. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2016]

Canonical amino-acid sequenceUniProt

520 residues, UniProt reviewed canonical sequence.

>Q16875|PFKFB3
     1  MPLELTQSRV QKIWVPVDHR PSLPRSCGPK LTNSPTVIVM VGLPARGKTY ISKKLTRYLN
    61  WIGVPTKVFN VGEYRREAVK QYSSYNFFRP DNEEAMKVRK QCALAALRDV KSYLAKEGGQ
   121  IAVFDATNTT RERRHMILHF AKENDFKAFF IESVCDDPTV VASNIMEVKI SSPDYKDCNS
   181  AEAMDDFMKR ISCYEASYQP LDPDKCDRDL SLIKVIDVGR RFLVNRVQDH IQSRIVYYLM
   241  NIHVQPRTIY LCRHGENEHN LQGRIGGDSG LSSRGKKFAS ALSKFVEEQN LKDLRVWTSQ
   301  LKSTIQTAEA LRLPYEQWKA LNEIDAGVCE ELTYEEIRDT YPEEYALREQ DKYYYRYPTG
   361  ESYQDLVQRL EPVIMELERQ ENVLVICHQA VLRCLLAYFL DKSAEEMPYL KCPLHTVLKL
   421  TPVAYGCRVE SIYLNVESVC THRERSEDAK KGPNPLMRRN SVTPLASPEP TKKPRINSFE
   481  EHVASTSAAL PSCLPPEVPT QLPGQNMKGS RSSADSSRKH

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against PFKFB3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.3
Highest tissue expression
535 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 535 nTPM
  • adipose tissue: 314 nTPM
  • bone marrow: 232 nTPM
  • kidney: 214 nTPM
  • breast: 156 nTPM
  • blood vessel: 123 nTPM

Single-cell type

  • neutrophils: 3,063 nCPM
  • monocytes: 750 nCPM
  • adipocytes: 532 nCPM
  • renal collecting duct principal cells: 499 nCPM
  • neutrophil progenitors: 402 nCPM
  • macrophages: 336 nCPM

Immune cell

  • neutrophil: 27 nTPM
  • intermediate monocyte: 9.2 nTPM
  • eosinophil: 7.8 nTPM
  • classical monocyte: 7.5 nTPM
  • MAIT T-cell: 5.7 nTPM
  • non-classical monocyte: 5.5 nTPM

Brain region

  • medulla oblongata: 339 nTPM
  • hypothalamus: 251 nTPM
  • white matter: 241 nTPM
  • midbrain: 239 nTPM
  • thalamus: 218 nTPM
  • spinal cord: 217 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.45
gnomAD pLI
0.25
gnomAD missense Z
1.66
DepMap mean gene effect
0.08
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads PFKFB3 as an antibody target. Whether an autoantibody or antibody against PFKFB3 could matter depends on whether native PFKFB3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

PFKFB3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label PFKFB3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/PFKFB3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...